Article Versions Notes

Noma T, Li Y, Wada Y, Morine Y, Ikemoto T, Saito Y, Yamada S, Teraoku H, Shimada M, Goel A. Oligomeric Proanthocyanidins Reverse Lenvatinib Resistance in Hepatocellular Carcinoma Through ITGA3-Mediated Pathway. Pharmaceuticals. 2025; 18(9):1361. https://doi.org/10.3390/ph18091361

Noma, Takayuki, Yuan Li, Yuma Wada, Yuji Morine, Tetsuya Ikemoto, Yu Saito, Shinichiro Yamada, Hiroki Teraoku, Mitsuo Shimada, and Ajay Goel. 2025. "Oligomeric Proanthocyanidins Reverse Lenvatinib Resistance in Hepatocellular Carcinoma Through ITGA3-Mediated Pathway" Pharmaceuticals 18, no. 9: 1361. https://doi.org/10.3390/ph18091361

Noma, T., Li, Y., Wada, Y., Morine, Y., Ikemoto, T., Saito, Y., Yamada, S., Teraoku, H., Shimada, M., & Goel, A. (2025). Oligomeric Proanthocyanidins Reverse Lenvatinib Resistance in Hepatocellular Carcinoma Through ITGA3-Mediated Pathway. Pharmaceuticals, 18(9), 1361. https://doi.org/10.3390/ph18091361